Amprion, Inc.
Biotechnology company · San Francisco, California, United States
Amprion, Inc. is a biotechnology company headquartered in San Francisco, California, United States. It has received 10 US government small-business research awards (SBIR/STTR) from health agencies, $11 million in total, most recently in 2021. It has reported private securities offerings to the US SEC, most recently $5.8 million sold in a notice filed in 2024.
Amprion at a glance
What does Amprion do?
US government research funding
10 SBIR/STTR small-business research awards from US health agencies, $11.2 million in total (2012 to 2021). NIH funding came from the National Institute on Aging, National Institute of Neurological Disorders and Stroke.
Private fundraising reported to the SEC
3 Form D notices; the most recent reported $5.8 million sold (2024).
Frequently asked questions about Amprion
Where is Amprion headquartered?
Amprion, Inc. is headquartered in San Francisco, California, United States.
What does Amprion do?
Amprion, Inc. is a biotechnology company.
Similar companies
- Ossium Health, Inc.San Francisco, California, United States
- Vir Biotechnology, Inc.San Francisco, California, United States
- Titan Pharmaceuticals IncSan Francisco, California, United States
- Senti Biosciences, Inc.San Francisco, California, United States
- Amygdala Neurosciences IncSan Francisco, California, United States
- Excision BioTherapeutics IncSan Francisco, California, United States
- ProLynx, Inc.San Francisco, California, United States
- Second Genome, Inc.San Francisco, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences